The 7 percent unemployment rate accompanied a gain of 203,000 jobs
A Needham & Co. report estimates that most cable TV channels would vanish if consumers could—as they say they'd prefer—spend $30 monthly on 15 to 20 channels
Challenges to patents, transparency for demand letters, and litigation fees are crucial
It lets customers go off the grid when utilities charge their highest rates and provides a backup during outages
The settlement ends an eight-year legal fight waged by African American brokers
Jeff Bezos's plan to deliver packages via unmanned aerial drones is crazy—which means you shouldn't bet against him
After selling out 5,000 designer Starbucks cards in six minutes last year, Starbucks is offering a mere 1,000 of them at noon on Friday
Northwestern's Kellogg School of Management reclaims the top stop after a two-year absence
Immigrant entrepreneurs and companies with intellectual property are more likely to hire
Founders: Dr. Mark Chandler and Craig Benson (The company was formed in 1998 as a wholly owned subsidiary of Luminex Corp. (LMNX) and subsequently spun off in 2002 as a private management-owned entity.)
VC Investment over the last four quarters: $25 million
With 95 employees worldwide, Rules-Based Medicine, a biomarker testing company, is actively developing diagnostic tests to detect the presence of complex diseases and conditions in the areas of neuropsychiatry, nephrology, immunology, and cardiology. The company is also developing what it calls the first fully closed reproducible whole-blood culture system. Despite the recession, Rules-Based Medicine's founders remain optimistic about its prospects and those of its peers that promote efficiency and cost savings for drug development and diagnostics customers.
Key to startup success: "We took a customer-focused approach to biotechnology, which drove our decision to commit resources to developing much needed comprehensive biomarker content. ... Our customers have essentially directed and funded our R&D since inception."